Background: While clinical prediction models (CPMs) are used increasingly commonly to
guide patient care, the performance and clinical utility of these CPMs in new patient cohorts is …

Background Clinical predictive models (CPMs) estimate the probability of clinical outcomes
and hold the potential to improve decision-making and individualize care. The Tufts …

METHODS We identified CPMs in the Tufts PACE CPM Registry, a systematic review of CVD-related
CPMs published from 1/1990-3/2015 (www. pace. tuftsmedicalcenter. org/cpm). 2 …

Background While many clinical prediction models ( CPM s) exist to guide valvular heart
disease treatment decisions, the relative performance of these CPM s is largely unknown. We …

Background. Cost-effectiveness analysis (CEA) estimates can vary substantially across patient
subgroups when patient characteristics influence preferences, outcome risks, treatment …

Methods| The study was exempted from review by the institutional review board at Tufts
Medical Center. We used data from 4 survey periods of the National Health and Nutrition …

In setting hemoglobin A1c (HbA1c) targets, physicians must consider individualized risks
and benefits of tight glycemic control (1, 2) by recognizing that the risk-benefit ratio may …

Background There are many clinical prediction models (CPMs) available to inform treatment
decisions, but little is known about the broad trustworthiness of these models and whether …

Managing patients with chronic kidney disease causes enormous financial burden on the
Ministry of Health and Medical Education. In addition, there is a lack of feedback and adequate …

Aim: Despite broad interest in advancing personalized medicine, most evidence is currently
derived from average results of clinical trials that may obscure heterogeneity of trial …